Skip to content

FDA patient committee to discuss virtual reality technology

FDA patient committee to discuss virtual reality technology
The FDA’s Patient Involvement Advisory Committee (PEAC) is an advisory committee formed to ensure that patients’ needs and experiences are included as part of the agency’s deliberations on medical device regulation.

At the meeting scheduled for July 12-13, PEAC members will provide recommendations on factors that FDA auditors should consider when evaluating the benefits and risks of AR/VR devices. The panel will also discuss specific challenges that AR/VR presents to vulnerable populations, such as children or those with cognitive disabilities.

The panel will also discuss how patient views can be incorporated into FDA and industry decision-making regarding the benefits and risks of AR/VR technology, as well as factors that healthcare providers should consider when considering AR/VR adoption.

More information about the meeting is available on the FDA’s website.

Copyright © 2022 AuntMinnie.com

Source link